Therapeutic induction of dytrophin-positive "revertant" fibres in the mdx mouse
Therapeutic induction of dytrophin-positive "revertant" fibres in the mdx mouse
批准号:
nhmrc : 303216
负责人:
Prof Stephen Wilton
金额:
$30.33万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-01-01 至 2006-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Revertant fibres are low-abundance, dystrophin-positive fibres found in muscle of DMD patients and animal models. These fibres appear to have a selective advantage over dystrophin negative fibres, as they accumulate with age. Characterisation of dystrophin mRNA has identified in-frame transcripts missing multiple exons, which either exclude a nonsense mutation or restore the reading frame around a deletion. We have designed antisense oligonucleotides (AOs) to bind regions flanking the exon containing the dystrophin mutation in the mdx mouse. The AOs interfere with processing of the pre-mRNA to exclude the mutation and allow a slightly shortened dystrophin to be synthesised. The use of AOs to modify RNA processing allows the gene to function under the control of natural regulatory elements. We have shown that AOs can induce dystrophin expression and improve strength in dystrophic (mdx) mouse hindlimb muscles. We aim to improve upon these results by using AOs to block splice sites flanking consecutive exons, in order to induce dystrophin which mimics that of revertant fibres. As most revertant transcripts are missing multiple exons, we believe that the functional capacity of AO-induced dystrophin can be improved upon by removing multiple exons. An mdx mouse skeletal muscle cell line is used for evaluation AOs. However, in order to determine the efficacy of the induced dystrophin in cardiac and skeletal muscle, experiments must be performed on mice. Previous work, in vitro and in muscles of mdx mice have validated this approach. Combinations of AOs which show promise will be delivered by a) intravascular injection b) intraperitoneal injection in mdx mice. The efficacy of the treatment will be assessed by both continual and end point analysis, which includes physiological, clinical, molecular and histological testing. Particular attention will be directed to the well-being of the mice and any adverse side effects which may occur.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antisense oligonucleotide induced exon skipping as a treatment for Duchenne Muscular Dystrophy
-
批准号:nhmrc : 139041
-
项目类别:NHMRC Project Grants
-
资助金额:$24.21万
-
财政年份:2001
-
负责人:Prof Stephen Wilton
-
依托单位:
国内基金
海外基金
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
-
批准号:82371791
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘永波
-
依托单位:
miRNA在毛乳头诱导毛囊再生中的作用及其机制
-
批准号:81171832
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:林常敏
-
依托单位:
诱导骨髓间充质干细胞分化为单倍体雄性生殖细胞
-
批准号:81070530
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:崔光辉
-
依托单位: